Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| S-Trityl-L-Cysteine SCHEMBL655692 | 1.00 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL6891349 | 0.98 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL768203 | 0.98 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL768202 | 0.98 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190175 | 0.97 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190178 | 0.97 | KIF11 (0.82) | KIF11DNMT1 | |
| SCHEMBL12851543 | 0.89 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14537506 | 0.88 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL7753308 | 0.86 | KIF11 (0.68) | KIF11DNMT1 | |
| SCHEMBL2838308 | 0.86 | KIF11 (0.68) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2837384-A1 | Glutathione based delivery system | Industrial Technology Research Institute (TW) | 2015-02-18 | — | — | EP | disclosed |
| EP-1891962-B1 | Glutathione based delivery system | IND TECH RES INST (TW) | 2014-08-13 | — | — | EP | disclosed |
| US-8673863-B2 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-03-18 | — | — | US | disclosed |
| US-8569239-B2 | Glutathione based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-10-29 | — | — | US | disclosed |
| US-20120046445-A1 | GLUTATHIONE-BASED DELIVERY SYSTEM | WANG AE-JUNE (TW) | 2012-02-23 | — | — | US | disclosed |
| US-8067380-B2 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2011-11-29 | — | — | US | disclosed |
| US-20100166849-A1 | GLUTATHIONE BASED DELIVERY SYSTEM | WANG AE-JUNE | 2010-07-01 | — | — | US | disclosed |
| US-7704956-B2 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-04-27 | — | — | US | disclosed |
| US-7700564-B2 | Glutathione based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-04-20 | — | — | US | disclosed |
| US-20090123531-A1 | GLUTATHIONE-BASED DELIVERY SYSTEM | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2009-05-14 | — | — | US | disclosed |
| US-20090060991-A1 | GLUTATHIONE BASED DELIVERY SYSTEM | WANG AE-JUNE | 2009-03-05 | — | — | US | disclosed |
| US-7446096-B2 | Glutathione based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2008-11-04 | — | — | US | disclosed |
| US-20080095836-A1 | Glutathione-based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2008-04-24 | — | — | US | disclosed |
| EP-1891962-A1 | Glutathione based delivery system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2008-02-27 | — | — | EP | disclosed |
| US-20070141133-A1 | Liposomes; analgesics; glutathione is covalently bound to polyethylene glycol,wherein the polyethylene glycol is covalently bound to vitamin E or a phospholipid | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046445-A1 | GLUTATHIONE-BASED DELIVERY SYSTEM | GSTO1, GPX4, GPX1 | KIF11 3642/4885DNMT1 2649/4885 |
| US-20100166849-A1 | GLUTATHIONE BASED DELIVERY SYSTEM | GPX4, GSTO1, GPX1 | KIF11 3612/4885DNMT1 2551/4885 |
| US-20070141133-A1 | Liposomes; analgesics; glutathione is covalently bound to polyethylene glycol,wherein the polyethylene glycol is covalently bound to vitamin E or a phospholipid | GSTO1, GSTP1, GSTA1 | KIF11 3404/4885DNMT1 2415/4885 |
| US-20080095836-A1 | Glutathione-based delivery system | GSTP1, GSS, GSTA1 | KIF11 3532/4885DNMT1 3858/4885 |
| US-20090060991-A1 | GLUTATHIONE BASED DELIVERY SYSTEM | GPX4, GSTO1, GPX1 | KIF11 3612/4885DNMT1 2551/4885 |
| US-20090123531-A1 | GLUTATHIONE-BASED DELIVERY SYSTEM | GSTO1, GPX4, GPX1 | KIF11 3642/4885DNMT1 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.